Human Tumor Necrosis Factor Receptor Superfamily Member 8 (TNFRSF8) Protein

Este producto es parte de TNFRSF8 - TNF receptor superfamily member 8
Product Graph
234€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Tumor Necrosis Factor Receptor Superfamily Member 8 (TNFRSF8) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx691145
tested applications
SDS-PAGE

Description

Tumor Necrosis Factor Receptor Superfamily Member 8 (TNFRSF8) protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Tumor Necrosis Factor Receptor Superfamily Member 8 (TNFRSF8)
Host
HEK293 cells
Assay Type
Activity: Not tested
Sequence Fragment: Phe19-Lys379
Tag: C-terminal Fc tag
Origin
Human
Observed MW
Calculated MW: 65.2 kDa  Observed MW (SDS-PAGE): 90-120 kDa
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Purification
0.2 µm filtered prior to lyophilization.
Size 1
10 µg
Size 2
50 µg
Form
Lyophilized
Tested Applications
SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4, containing 5%-8% Trehalose, Mannitol and 0.01% Tween 80.
Availability
Shipped within 5-15 working days.
Storage
Storage: Store lyophilized between -20 °C and -80°C.
Stability: Stable when stored reconstituted at 2-8°C for up to 1 week. Reconstituted aliquots are stable at -20°C for up to 3 months.
Shelf Life: 12 months.
Dry Ice
No
UniProt ID
P28908
Gene ID
943
OMIM
153243
Alias
CD30,Ki-1,D1S166E,CD30L receptor,Lymphocyte activation antigen CD30,Tumor necrosis factor receptor superfamily member 8
Background
Protein TNFRSF8
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in sterile H2O to prepare a stock solution of concentration 0.25 mg/ml. Do not vortex.
Endotoxin Level: < 1.0 EU per µg (LAL method).

Descripción

TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily Member 8), also known as CD30, is a cell surface receptor belonging to the tumor necrosis factor receptor (TNFR) superfamily. This family is composed of receptors that play critical roles in modulating immune responses, inflammation, and apoptosis. CD30 is primarily expressed on activated T and B cells, and its expression is upregulated in certain immune-related diseases and cancers, particularly Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). It has emerged as a significant target in cancer immunotherapy and as a diagnostic marker for lymphoma. The receptor is a hallmark of classical Hodgkin lymphoma (cHL) and ALCL due to its overexpression on malignant cells. Beyond cancer, CD30 has implications in the regulation of immune homeostasis, playing a role in T-cell activation, differentiation, and proliferation. Dysregulation of CD30 signaling can lead to chronic inflammation and the development of autoimmune disorders, making it an essential molecule of interest in both oncology and immunology.

Related Products

EH0640

Human TNFRSF8 (Tumor necrosis factor receptor superfamily member 8) ELISA Kit

Ver Producto
EMK0203

Monkey CD30 (Lymphocyte activation antigen CD30) ELISA Kit

Ver Producto
ER0220

Rat Tnfrsf8 (Tumor necrosis factor receptor superfamily member 8) ELISA Kit

Ver Producto